Pictures of
the current EyeTect® TMU prototype are below.
EyeTect’s TMU has been proven effective in clinical studies,
and has received 510(k) clearance from the USFDA for use in
the OR and ICU (See Appendix A), as well as patent
protection from the USPTO.
The EyeTect®
TMU system provides an easy-to-use method of measuring OMT
through a closed eyelid and displaying the measurements in
real time on a standard patient monitor or a freestanding
monitor. A small sensor is placed on the patient’s closed
eyelid that picks up the micro-movement through the eyelid.
The OMT frequency, amplitude, waveform, and trend over time
are then instantaneously displayed on the TMU or bedside
monitor.
